IRIS Accounts Production v24.3.2.46 10348310 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 5352 5352 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh103483102023-03-31103483102024-03-31103483102023-04-012024-03-31103483102022-03-31103483102022-04-012023-03-31103483102023-03-3110348310ns15:EnglandWales2023-04-012024-03-3110348310ns14:PoundSterling2023-04-012024-03-3110348310ns10:Director12023-04-012024-03-3110348310ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3110348310ns10:SmallEntities2023-04-012024-03-3110348310ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3110348310ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3110348310ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3110348310ns10:FullAccounts2023-04-012024-03-3110348310ns10:OrdinaryShareClass12023-04-012024-03-3110348310ns10:OrdinaryShareClass22023-04-012024-03-3110348310ns10:Director2422023-04-012024-03-3110348310ns10:Director2422024-03-3110348310ns10:Director22023-04-012024-03-3110348310ns10:RegisteredOffice2023-04-012024-03-3110348310ns5:CurrentFinancialInstruments2024-03-3110348310ns5:CurrentFinancialInstruments2023-03-3110348310ns5:Non-currentFinancialInstruments2024-03-3110348310ns5:Non-currentFinancialInstruments2023-03-3110348310ns5:ShareCapital2024-03-3110348310ns5:ShareCapital2023-03-3110348310ns5:RetainedEarningsAccumulatedLosses2024-03-3110348310ns5:RetainedEarningsAccumulatedLosses2023-03-3110348310ns5:PlantMachinery2023-03-3110348310ns5:PlantMachinery2023-04-012024-03-3110348310ns5:PlantMachinery2024-03-3110348310ns5:PlantMachinery2023-03-3110348310ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3110348310ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3110348310ns5:DeferredTaxation2023-03-3110348310ns5:DeferredTaxation2023-04-012024-03-3110348310ns5:DeferredTaxation2024-03-3110348310ns10:OrdinaryShareClass12024-03-3110348310ns10:OrdinaryShareClass22024-03-31103483101ns10:Director12023-03-31103483101ns10:Director12022-03-31103483101ns10:Director12023-04-012024-03-31103483101ns10:Director12022-04-012023-03-31103483101ns10:Director12024-03-31103483101ns10:Director12023-03-31
REGISTERED NUMBER: 10348310 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2024

for

A & A SURGICAL LIMITED

A & A SURGICAL LIMITED (REGISTERED NUMBER: 10348310)






Contents of the Financial Statements
for the year ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


A & A SURGICAL LIMITED

Company Information
for the year ended 31 March 2024







DIRECTORS: A Symes
A Symes





REGISTERED OFFICE: Preston Park House
South Road
Brighton
East Sussex
BN1 6SB





REGISTERED NUMBER: 10348310 (England and Wales)





ACCOUNTANTS: Plus Accounting
Chartered Accountants
Preston Park House
South Road
Brighton
East Sussex
BN1 6SB

A & A SURGICAL LIMITED (REGISTERED NUMBER: 10348310)

Balance Sheet
31 March 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 4 1,498 2,435

CURRENT ASSETS
Debtors 5 21,040 10,317
Cash at bank and in hand 35,357 43,796
56,397 54,113
CREDITORS
Amounts falling due within one year 6 (34,427 ) (26,498 )
NET CURRENT ASSETS 21,970 27,615
TOTAL ASSETS LESS CURRENT
LIABILITIES

23,468

30,050

CREDITORS
Amounts falling due after more than one
year

7

(6,489

)

(11,875

)

PROVISIONS FOR LIABILITIES 8 (186 ) (560 )
NET ASSETS 16,793 17,615

CAPITAL AND RESERVES
Called up share capital 9 2 2
Retained earnings 16,791 17,613
SHAREHOLDERS' FUNDS 16,793 17,615

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

A & A SURGICAL LIMITED (REGISTERED NUMBER: 10348310)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 January 2025 and were signed on its behalf by:





A Symes - Director


A & A SURGICAL LIMITED (REGISTERED NUMBER: 10348310)

Notes to the Financial Statements
for the year ended 31 March 2024

1. STATUTORY INFORMATION

A & A Surgical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the fair value of consideration received or receivable net of VAT and trade discounts. Revenue from the providing medical services is recongnised in period in which services have been provided.

Tangible fixed assets
Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended by management.

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Going concern
The directors have a reasonable expectation that the company has adequate resources to continue in existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

A & A SURGICAL LIMITED (REGISTERED NUMBER: 10348310)

Notes to the Financial Statements - continued
for the year ended 31 March 2024

2. ACCOUNTING POLICIES - continued

Impairment
At each balance sheet date, the company reviews the carrying amount of its assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any. Where it is not possible to estimate the recoverable amount of an asset, the Company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2023
and 31 March 2024 2,840
DEPRECIATION
At 1 April 2023 405
Charge for year 937
At 31 March 2024 1,342
NET BOOK VALUE
At 31 March 2024 1,498
At 31 March 2023 2,435

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 15,688 10,317
Other debtors 5,352 -
21,040 10,317

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 5,386 5,129
Taxation and social security 27,816 19,867
Other creditors 1,225 1,502
34,427 26,498

A & A SURGICAL LIMITED (REGISTERED NUMBER: 10348310)

Notes to the Financial Statements - continued
for the year ended 31 March 2024

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans 6,489 11,875

8. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 186 560

Deferred
tax
£   
Balance at 1 April 2023 560
Credit to Income Statement during year (374 )
Balance at 31 March 2024 186

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1 Ordinary A £1 1 1
1 Ordinary B £1 1 1
2 2

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2024 and 31 March 2023:

2024 2023
£    £   
A Symes and A Symes
Balance outstanding at start of year - -
Amounts advanced 5,352 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 5,352 -

Director's loan is interest free and repayable on demand.